mash glp 1 The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, and MASLD/ in Type 2 Diabetes Mellitus: A Narrative Review What you need to know

GLP-1s started as drugs to help patients with diabetes, but their success as a weight loss treatment helped boost their popularity

The rising prevalence of diabetes and obesity, growing research and development activities, and increasing investments drive the market

Shedding excess weight can also reduce the risk of heart disease, high blood pressure, and high cholesterol

The adjustments are small: a to-go box, a protein and fiber anchor on the plate, and a post-meal walk around the block

Current evidence suggests GLP-1 receptor activation in the brain contributes to reduced food intake, altered food preferences, improved glycemic control, and potentially neuroprotective effects